Abstract
IntroductionBarrett’s oesophagus (BO) affects 1–5% of reflux patients and has a premalignant potential. Several guidelines 1,2,3 to optimise surveillance are tailored towards discovering dysplasia and hence allow treatment and prevention...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
